{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T15:21:18Z","timestamp":1779895278109,"version":"3.53.1"},"update-to":[{"DOI":"10.1371\/journal.pmed.1003730","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2021,9,10]],"date-time":"2021-09-10T00:00:00Z","timestamp":1631232000000}}],"reference-count":34,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2021,8,26]],"date-time":"2021-08-26T00:00:00Z","timestamp":1629936000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Fundation of China","doi-asserted-by":"crossref","award":["71704149"],"award-info":[{"award-number":["71704149"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.plosmedicine.org"],"crossmark-restriction":false},"short-container-title":["PLoS Med"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Background<\/jats:title>\n<jats:p>Adherence to oral anticoagulant therapy in patients with atrial fibrillation (AF) in China is low. Patient preference, one of the main reasons for discontinuation of oral anticoagulant therapy, is an unfamiliar concept in China.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Methods and findings<\/jats:title>\n<jats:p>A discrete choice experiment (DCE) was conducted to quantify patient preference on 7 attributes of oral anticoagulant therapy: antidote (yes\/no), food\u2013drug interaction (yes\/no), frequency of blood monitoring (no need, every 6\/3\/1 month[s]), risk of nonfatal major bleeding (0.7\/3.1\/5.5\/7.8[%]), risk of nonfatal stroke (ischemic\/hemorrhagic) or systemic embolism (0.6\/3.2\/5.8\/8.4[%]), risk of nonfatal acute myocardial infarction (AMI) (0.2\/1.0\/1.8\/2.5[%]), and monthly out-of-pocket cost (0\/120\/240\/360 RMB) (0 to 56 USD). A total of 16 scenarios were generated by using D-Efficient design and were randomly divided into 2 blocks. Eligible patients were recruited and interviewed from outpatient and inpatient settings of 2 public hospitals in Beijing and Shenzhen, respectively. Patients were presented with 8 scenarios and asked to select 1 of 3 options: 2 unlabeled hypothetical treatments and 1 opt-out option. Mixed logit regression model was used for estimating patients\u2019 preferences of attributes of oral anticoagulants and willingness to pay (WTP) with adjustments for age, sex, education level, income level, city, self-evaluated health score, histories of cardiovascular disease\/other vascular disease\/any stroke\/any bleeding, and use of anticoagulant\/antiplatelet therapy. A total of 506 patients were recruited between May 2018 and December 2019 (mean age 70.3 years, 42.1% women). Patients were mainly concerned about the risks of AMI (\u03b2: \u22121.03; 95% CI: \u22121.31, \u22120.75; <jats:italic>p<\/jats:italic> &lt; 0.001), stroke or systemic embolism (\u03b2: \u22120.81; 95% CI: \u22120.90, \u22120.73; <jats:italic>p<\/jats:italic> &lt; 0.001), and major bleeding (\u03b2: \u22120.69; 95% CI: \u22120.78, \u22120.60; <jats:italic>p<\/jats:italic> &lt; 0.001) and were willing to pay more, from up to 798 RMB to 536 RMB (124 to 83 USD) monthly. The least concerning attribute was frequency of blood monitoring (\u03b2: \u22120.31; 95% CI: \u22120.39, \u22120.24; <jats:italic>p<\/jats:italic> &lt; 0.001). Patients had more concerns about food\u2013drug interactions even exceeding preferences on the 3 risks, if they had a history of stroke or bleeding (\u03b2: \u22122.47; 95% CI: \u22123.92, \u22121.02; <jats:italic>p<\/jats:italic> &lt; 0.001), recruited from Beijing (\u03b2: \u22121.82; 95% CI: \u22122.56, \u22121.07; <jats:italic>p<\/jats:italic> &lt; 0.001), or men (\u03b2: \u22120.96; 95% CI: \u22121.36, \u22120.56; <jats:italic>p<\/jats:italic> &lt; 0.001). Patients with lower educational attainment or lower income weighted all attributes lower, and their WTP for incremental efficacy and safety was minimal. Since the patients were recruited from 2 major hospitals from developed cities in China, further studies with better representative samples would be needed.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Conclusions<\/jats:title>\n<jats:p>Patients with AF in China were mainly concerned about the safety and effectiveness of oral anticoagulant therapy. The preference weighting on food\u2013drug interaction varied widely. Patients with lower educational attainment or income levels and less experience of bleeding or stroke had more reservations about paying for oral anticoagulant therapies with superior efficacy, safety, and convenience of use.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pmed.1003730","type":"journal-article","created":{"date-parts":[[2021,8,26]],"date-time":"2021-08-26T17:57:32Z","timestamp":1630000652000},"page":"e1003730","update-policy":"https:\/\/doi.org\/10.1371\/journal.pmed.corrections_policy","source":"Crossref","is-referenced-by-count":18,"title":["Importance of attributes and willingness to pay for oral anticoagulant therapy in patients with atrial fibrillation in China: A discrete choice experiment"],"prefix":"10.1371","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3875-808X","authenticated-orcid":true,"given":"Jiaxi","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4082-9350","authenticated-orcid":true,"given":"Hao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4836-7808","authenticated-orcid":true,"given":"Xue","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5225-3032","authenticated-orcid":true,"given":"Vincent K. C.","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6895-6071","authenticated-orcid":true,"given":"Carlos K. H.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7626-7751","authenticated-orcid":true,"given":"Yutao","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5940-5737","authenticated-orcid":true,"given":"Marco K. H.","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7566-1626","authenticated-orcid":true,"given":"Gregory Y. H.","family":"Lip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2666-3086","authenticated-orcid":true,"given":"Chung-Wah","family":"Siu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9578-7808","authenticated-orcid":true,"given":"Hung-Fat","family":"Tse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther W.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2021,8,26]]},"reference":[{"issue":"2","key":"pmed.1003730.ref001","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1177\/1747493019897870","article-title":"Global epidemiology of atrial fibrillation: an increasing epidemic and public health challenge","volume":"16","author":"G Lippi","year":"2020","journal-title":"Int J Stroke."},{"issue":"5","key":"pmed.1003730.ref002","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.amjcard.2018.05.015","article-title":"The disease burden of atrial fibrillation in China from a national cross-sectional survey","volume":"122","author":"Z Wang","year":"2018","journal-title":"Am J Cardiol"},{"issue":"16","key":"pmed.1003730.ref003","doi-asserted-by":"crossref","first-page":"322","DOI":"10.21037\/atm.2017.06.65","article-title":"Direct oral anticoagulants: analysis of worldwide use and popularity using Google Trends","volume":"5","author":"G Lippi","year":"2017","journal-title":"Ann Transl Med"},{"issue":"21","key":"pmed.1003730.ref004","first-page":"e1","article-title":"2014 AHA\/ACC\/HRS Guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society","volume":"64","author":"CT January","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"pmed.1003730.ref005","doi-asserted-by":"crossref","first-page":"e125","DOI":"10.1161\/CIR.0000000000000665","article-title":"2019 AHA\/ACC\/HRS focused update of the 2014 AHA\/ACC\/HRS Guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in collaboration with the society of thoracic Surgeons","volume":"140","author":"CT January","year":"2019","journal-title":"Circulation"},{"issue":"16","key":"pmed.1003730.ref006","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1093\/eurheartj\/ehy136","article-title":"The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation","volume":"39","author":"J Steffel","year":"2018","journal-title":"Eur Heart J"},{"issue":"1","key":"pmed.1003730.ref007","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jacc.2019.01.011","article-title":"2019 AHA\/ACC\/HRS focused update of the 2014 AHA\/ACC\/HRS Guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society","volume":"74","author":"CT January","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"9\u201310","key":"pmed.1003730.ref008","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1111\/jocn.14797","article-title":"Persistence and outcomes of non-vitamin K antagonist oral anticoagulants versus warfarin in patients with non-valvular atrial fibrillation","volume":"28","author":"S Wu","year":"2019","journal-title":"J Clin Nurs"},{"key":"pmed.1003730.ref009","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.12659\/MSM.915875","article-title":"Long-term persistence with newly-initiated warfarin or non-VKA oral anticoagulant (NOAC) in patients with non-valvular atrial fibrillation: insights from the prospective China-AF registry","volume":"25","author":"C Liu","year":"2019","journal-title":"Med Sci Monit"},{"issue":"1","key":"pmed.1003730.ref010","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1186\/s12913-020-5072-3","article-title":"Trends of ambulatory oral anticoagulant prescription in five major cities of China, 2012\u20132017","volume":"20","author":"Z Yu","year":"2020","journal-title":"BMC Health Serv Res"},{"issue":"1","key":"pmed.1003730.ref011","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s12872-020-01330-6","article-title":"Current status and factors influencing oral anticoagulant therapy among patients with non-valvular atrial fibrillation in Jiangsu province, China: a multi-center, cross-sectional study","volume":"20","author":"T Liu","year":"2020","journal-title":"BMC Cardiovasc Disord"},{"issue":"11","key":"pmed.1003730.ref012","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1007\/s40273-014-0188-0","article-title":"Preferences for oral anticoagulants in atrial fibrillation: a best-best discrete choice experiment","volume":"32","author":"P Ghijben","year":"2014","journal-title":"Pharmacoeconomics"},{"issue":"4","key":"pmed.1003730.ref013","doi-asserted-by":"crossref","first-page":"304","DOI":"10.4065\/mcp.2010.0575","article-title":"Medication adherence: WHO cares?","volume":"86","author":"MT Brown","year":"2011","journal-title":"Mayo Clin Proc"},{"issue":"1","key":"pmed.1003730.ref014","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s13643-019-1014-8","article-title":"Medication adherence influencing factors-an (updated) overview of systematic reviews","volume":"8","author":"A Gast","year":"2019","journal-title":"Syst Rev"},{"issue":"8","key":"pmed.1003730.ref015","doi-asserted-by":"crossref","first-page":"e027153","DOI":"10.1136\/bmjopen-2018-027153","article-title":"A protocol for a discrete choice experiment: understanding patient medicine preferences for managing chronic non-cancer pain","volume":"9","author":"M Shanahan","year":"2019","journal-title":"BMJ Open"},{"issue":"4","key":"pmed.1003730.ref016","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.jval.2016.01.001","article-title":"Physician and patient preferences for nonvalvular atrial fibrillation therapies","volume":"19","author":"J Shafrin","year":"2016","journal-title":"Value Health"},{"issue":"6","key":"pmed.1003730.ref017","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1161\/CIRCOUTCOMES.114.001013","article-title":"Patients\u2019 preferences in anticoagulant therapy: discrete choice experiment.","volume":"7","author":"M Najafzadeh","year":"2014","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"4","key":"pmed.1003730.ref018","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.jval.2010.11.013","article-title":"Conjoint analysis applications in health\u2014a checklist: a report of the ISPOR Good Research Practices for Conjoint Analysis Task Force","volume":"14","author":"JF Bridges","year":"2011","journal-title":"Value Health"},{"issue":"5","key":"pmed.1003730.ref019","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1093\/europace\/euv116","article-title":"Preference for oral anticoagulation therapy for patients with atrial fibrillation in Europe in different clinical situations: results of the European Heart Rhythm Association Survey","volume":"17","author":"TB Larsen","year":"2015","journal-title":"Europace"},{"key":"pmed.1003730.ref020","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.vhri.2015.03.016","article-title":"Comparing patient and physician risk tolerance for bleeding events associated with anticoagulants in atrial fibrillation-evidence from the United States and Japan","volume":"6","author":"K Okumura","year":"2015","journal-title":"Value Health Reg Issues"},{"issue":"1","key":"pmed.1003730.ref021","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s40271-016-0185-9","article-title":"Patient preferences for oral anticoagulation therapy in atrial fibrillation: a systematic literature review.","volume":"10","author":"T Wilke","year":"2017","journal-title":"Patient"},{"issue":"38","key":"pmed.1003730.ref022","doi-asserted-by":"crossref","first-page":"2882","DOI":"10.1093\/eurheartj\/ehw233","article-title":"Two-year outcomes of patients with newly diagnosed atrial fibrillation: results from GARFIELD-AF","volume":"37","author":"JP Bassand","year":"2016","journal-title":"Eur Heart J"},{"issue":"12","key":"pmed.1003730.ref023","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.006475","article-title":"Prevalence, characteristics, and outcomes of valvular heart disease in patients with atrial fibrillation: insights from the ORBIT-AF (Outcomes Registry for Better Informed Treatment for Atrial Fibrillation)","volume":"6","author":"KL Thomas","year":"2017","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"pmed.1003730.ref024","doi-asserted-by":"crossref","first-page":"e0191592","DOI":"10.1371\/journal.pone.0191592","article-title":"Risk factors for death, stroke, and bleeding in 28,628 patients from the GARFIELD-AF registry: rationale for comprehensive management of atrial fibrillation","volume":"13","author":"JP Bassand","year":"2018","journal-title":"PLoS ONE"},{"issue":"5","key":"pmed.1003730.ref025","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.003347","article-title":"Atrial fibrillation and myocardial infarction: a systematic review and appraisal of pathophysiologic mechanisms.","volume":"5","author":"F Violi","year":"2016","journal-title":"J Am Heart Assoc"},{"issue":"19","key":"pmed.1003730.ref026","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1001\/jama.2015.4369","article-title":"Stroke prevention in atrial fibrillation: a systematic review","volume":"313","author":"GY Lip","year":"2015","journal-title":"JAMA"},{"issue":"14","key":"pmed.1003730.ref027","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1093\/eurheartj\/ehv466","article-title":"XANTUS: a real-world, prospective, observational study of patients treated with rivaroxaban for stroke prevention in atrial fibrillation","volume":"37","author":"AJ Camm","year":"2016","journal-title":"Eur Heart J"},{"issue":"11","key":"pmed.1003730.ref028","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1503\/cmaj.060837","article-title":"Influence of decision aids on patient preferences for anticoagulant therapy: a randomized trial.","volume":"176","author":"A Holbrook","year":"2007","journal-title":"CMAJ"},{"issue":"2","key":"pmed.1003730.ref029","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1524-4733.2009.00670.x","article-title":"Labeled versus unlabeled discrete choice experiments in health economics: an application to colorectal cancer screening","volume":"13","author":"EW de Bekker-Grob","year":"2010","journal-title":"Value Health"},{"issue":"11","key":"pmed.1003730.ref030","doi-asserted-by":"crossref","first-page":"e111805","DOI":"10.1371\/journal.pone.0111805","article-title":"The effect of including an opt-out option in discrete choice experiments","volume":"9","author":"J Veldwijk","year":"2014","journal-title":"PLoS ONE"},{"key":"pmed.1003730.ref031","author":"BK Orme","year":"2019"},{"issue":"4","key":"pmed.1003730.ref032","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.jval.2016.04.004","article-title":"Statistical methods for the analysis of discrete choice experiments: a report of the ISPOR Conjoint Analysis Good Research Practices Task Force","volume":"19","author":"AB Hauber","year":"2016","journal-title":"Value Health"},{"issue":"1","key":"pmed.1003730.ref033","first-page":"164","article-title":"Hierarchical two-step floating catchment area (2SFCA) method: measuring the spatial accessibility to hierarchical healthcare facilities in Shenzhen.","volume":"19","author":"Z Tao","journal-title":"China Int J Equity Health. 2020"},{"issue":"2","key":"pmed.1003730.ref034","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1080\/03007995.2017.1391760","article-title":"Real world adherence to oral anticoagulant in non-valvular atrial fibrillation patients in China.","volume":"34","author":"X Xiang","year":"2018","journal-title":"Curr Med Res Opin"}],"updated-by":[{"DOI":"10.1371\/journal.pmed.1003730","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2021,9,10]],"date-time":"2021-09-10T00:00:00Z","timestamp":1631232000000}}],"container-title":["PLOS Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pmed.1003730","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,10]],"date-time":"2021-09-10T17:54:38Z","timestamp":1631296478000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pmed.1003730"}},"subtitle":[],"editor":[{"given":"Suzanne C.","family":"Cannegieter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2021,8,26]]},"references-count":34,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2021,8,26]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pmed.1003730","relation":{"new_version":[{"id-type":"doi","id":"10.1371\/journal.pmed.1003730","asserted-by":"object"}]},"ISSN":["1549-1676"],"issn-type":[{"value":"1549-1676","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,26]]}}}